- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05089799
" Socially Pertinent Robot in Gerontological Healthcare " (Spring)
Study Overview
Status
Intervention / Treatment
Detailed Description
Elderly people suffering from neurocognitive disorders require multimodal support (social, medical, associative) in which Socially Assistive Robots (SARs) could intervene in order to improve the physical and psychological well-being of elderly people and maintain their quality of life. SARs are social entities capable of interacting with their users in a variety of contexts (informational, recreational, educational). These robots also offer promising possibilities for accompanying care workers in their support of people with neurodegenerative diseases. However, up to date, these robots are not sufficiently sophisticated to engage in satisfactory social interactions with human beings and lead to their adoption.
The SPRING study is a non-interventional study that does not include objectives for improving health or patient care. It is an exploratory study targeting five use cases with a social robot and three populations of care hospital users (patients, informal or family caregivers and professionals). No follow-up of the participants is necessary.
The main objective of SPRING is to study the acceptability of socially assistive robots among three actors in a hospital service: patients, informal or family caregivers and professionals. The secondary objectives are to study a) the usability of the ARI robot among day care hospital's users which is necessary to understand the efficiency of using the robot in this context; b) the organisational impact of the robot on the operation of the service among day care hospital's professionals ; c) the ethical questions generated by the presence of the robot with the participants that will allow us to extend our understanding of the determinants of the rejection or adoption of new technologies in the hospital context.
During this non-interventional and exploratory research, the ARI robot will be tested in the waiting room of a day care hospital in a geriatric hospital regarding five use cases (1/welcoming patients and family members to the hospital, 2/ providing a reminder how to follow sanitary gestures for the prevention of virus transmission, 3/providing patients an assistance to prepare for the medical consultation that will follow during the day, 4/ providing orientation and guidance in relation to the location (hospital) and the services available (toilets, cafeteria, elevators, etc.) and 5/Providing entertainment to patients and families during the waiting time.
Patients and their family caregivers meet the robot only once. They answer questionnaires and participate in semi-structured interviews after interacting with the robot. Evaluations target the acceptability, usability and ethical issues raised by the presence of a robotic agent in support of care teams.
The professionals included in the study meet the robot several times according to their professional obligations (hospital practitioners are not present every day at the day care hospital and can choose when to interact with the robot). They will be invited to participate in two focus groups, one before the introduction of the robot and the other one at the end of the study. At the end of the study, the investigators will offer them to fill in questionnaires and participate in semi-structured interviews. The evaluations proposed to the professionals deal with questions of acceptability, usability, organisational impact of the robot's presence, and ethical issues related to its presence in the day care hospital.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: PINO Maribel, PhD, Research Engineer
- Phone Number: 00 33 1 44 08 33 51
- Email: maribel.pino@aphp.fr
Study Contact Backup
- Name: BENHAMMANI-GODARD Marie
- Phone Number: 00 33 1 58 41 11 90
- Email: marie.godard@aphp.fr
Study Locations
-
-
Ile De France
-
Paris, Ile De France, France, 75013
- Recruiting
- Assistance Publique - Hôpitaux de Paris (AP-HP) - Broca Hospital - Geriatric unit
-
Contact:
- Anne-Sophie RIGAUD
- Email: anne-sophie.rigaud@aphp.fr
-
Contact:
- Marie BENHAMMANI-GODARD
- Email: marie.godard@aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
The population includes the 3 categories of actors attending the day care hospital: patients, their carers (family or close carers) and professionals. The investigators will consider all the actors who are likely to interact with the ARI social robot, including people who are not formally part of the patients' care pathway, but whose presence is important to their care.
The individuals included will have various profiles, from a demographic, sociological and clinical point of view. The patients and their carers mainly live in the Paris region.
Patients mainly consult the day care hospital for memory problems, but are likely to display associated cognitive, behavioural or physical problems.
Description
Inclusion Criteria:
- PATIENTS
- Age 60 and over
- Enough knowledge in French language
- Without distinction of gender, socio-professional categories or ethnic origin
- MMSE > 10
- No symptoms of altered reality (delirium, hallucination, frontal disinhibition, etc.).
- Having expressed his/her non-opposition to his/her participation in the study or to being in the presence of the robot
- If the persons are protected adults under guardianship, the tutor or legal guardian has expressed his/her non-opposition to participate in the study or to be in the presence of the robot for the person concerned.
- ACCOMPANYING PERSONS
- They are all adults who have enough knowledge in French language.
- They are enrolled without distinction of gender, socio-professional categories or ethnic origin
- They have expressed his/her non-opposition to participate in the study
- PROFESSIONALS:
- Age 18 and over.
- Has expressed his/her non-opposition to participate in the study
Exclusion Criteria:
- PATIENTS
- They have expressed, or where applicable, their family, guardian or legal representative, their opposition to participate in the study or their opposition to be in the presence of the robot.
- PAtients benefiying of Medical State Aid (French AME)
- ACCOMPANYING PERSONS They are under 18. They do not have enough knowledge in French language to understand simple instructions. They have expressed their opposition to participate in the study or their opposition to be in the presence of the robot.
- PROFESSIONNALS They have expressed their opposition to participate in the study or their opposition to be in the presence of the robot.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients
Older adults 60 years old or older They are referred to the day care hospital for memory problems or frailty and may present with various cognitive, behavioural, mental and physical disorders. Persons in this group are diverse in socio-cultural levels. The investigators expect to include 100 patients (N = 100). Each patient will test 1 out of the 5 use cases, so 20 patients will test the same use case (n = 20). |
Description of scenarios involving robot and users
|
Informal carers or family caregivers
This group includes persons who accompany patients during the hospital visit, such as family members (spouses or children) and friends. They provide support to the patient with various frequency and intensity (occasional / regular / continuous). Persons in this group are diverse in age and socio-cultural levels. They may also suffer from physical and/or psychological disorders. The investigators expect to include 100 informal or family caregivers (N = 100). Each one will test 1 out of the 5 use cases, so 20 informal or family caregivers will test the same use case (n= 20). |
Description of scenarios involving robot and users
|
Professionals
All categories of professionals working in the day care hospital. Persons in this group belong to different professional categories (administrative, health, technical). They have different levels of proximity with the public and have various positions in the hospital. The investigators expect to include 50 professionals. |
Description of scenarios involving robot and users
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability E-Scale (AE-S)
Time Frame: Inclusion visit
|
This criterion will be evaluated with patients, informal or family caregivers and professionals, on the basis of the French version of the "Acceptability E-Scale" (AE-S), a six items questionnaire rated with a Likert scale from 1 to 5 (Micoulaud-Franchi et al., 2016). The items have been adapted for a use with a robot. On the day of the appointment at the day care hospital for patients and their informal or family caregivers. During the experiment for professionals. One session, approximatively 10 minutes length. |
Inclusion visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
System Usability Scale (SUS)
Time Frame: Inclusion visit
|
The SUS is a 10 items questionnaire rated with a Likert scale from 1 to 5 (Brooke, 1996). Usability will also be evaluated with observations during interactions between participants and the robot. On the day of the appointment at the day care hospital for patients and their carers. During the experiment for professionals. On session, approximatively, 15 minutes length. |
Inclusion visit
|
Semi-structured interview (10 questions) based on the USUS model (Hebesberger et al., 2017)
Time Frame: Inclusion visit
|
The organisational impactwill be evaluated with the professionals at the end of the experiment using a semi-structured interview (10 questions) based on the USUS model (Hebesberger et al., 2017). During the experiment for professionals. One session, approximatively 15 minutes length. |
Inclusion visit
|
Semi-structured interview (6 questions)
Time Frame: Inclusion visit
|
Ethical aspects will be assessed by means of a semi-structured interview (6 questions) with day care hospital's users based on the ethical questions included in the acceptability questionnaire based on the UTAUT model (Alaiad & Zhou, 2014) and through an adaptation of some items of the "Ethical Acceptability Scale" (Peca, 2016). On the day of the appointment at the day care hospital for patients and their carers. During the experiment for professionals. One session, approximatively 15 minutes length. |
Inclusion visit
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: RIGAUD Anne-Sophie, Assistance Publique - Hôpitaux de Paris
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- APHP201352
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Participation
-
Wolfson Medical CenterRecruiting
-
Yale UniversityFood and Drug Administration (FDA)CompletedPatient ParticipationUnited States
-
NHS GrampianNot yet recruitingPatient Participation
-
GuerbetNot yet recruiting
-
Aversi ClinicUnknownPatient ParticipationGeorgia
-
Columbia UniversityMedical University of South Carolina; Northwestern UniversityCompleted
-
Radboud University Medical CenterJeroen Bosch ZiekenhuisUnknownCommunication | Patient ParticipationNetherlands
-
Pamukkale UniversityAkdeniz UniversityCompletedChild, Only | Participation, PatientTurkey
-
Lund UniversitySkane University HospitalNot yet recruitingPatient Participation | Heart Rate Determination
-
University Hospital, GhentUniversity GhentCompletedPatient Participation | Nursing | Bedside Shift ReportBelgium
Clinical Trials on Exposure and interaction with a socially assistive robot
-
University of BedfordshireÖrebro University, Sweden; Nagoya University; Università degli Studi of Genova; Middlesex University and other collaboratorsUnknown
-
University of ExtremaduraCompleted
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
Helse Møre og Romsdal HFSINTEF Health Research; Kristiansund municipality; Centre for Health Innovation; Hospital Pharmacy of Central Norway TrustRecruiting
-
University of RzeszowDonum Corde Rehabilitation CenterNot yet recruitingNervous System Diseases | Physical Activity | Neurorehabilitation | Biomedical Enhancement
-
Epitel, Inc.University of Colorado, Denver; National Institute of Neurological Disorders... and other collaboratorsEnrolling by invitation
-
National Cancer Institute (NCI)CompletedRecurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Germ Cell Tumor | Recurrent Ovarian Germ Cell Tumor | Stage III Testicular Cancer | Recurrent Malignant Testicular Germ Cell Tumor | Recurrent Extragonadal Seminoma | Recurrent Malignant Extragonadal Germ Cell Tumor | Recurrent Malignant Extragonadal Non-Seminomatous Germ Cell... and other conditionsUnited States
-
Children's Oncology GroupRecruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia of Ambiguous Lineage | Recurrent Acute Leukemia of Ambiguous Lineage | Recurrent Acute Myeloid Leukemia... and other conditionsUnited States